WELL Health vs. CloudMD: Which TSX Growth Stock Should You Buy Right Now?

WELL Health and CloudMD are two health-tech stocks that have the potential to deliver outsized gains to long-term investors.

| More on:

In the past decade, growth stocks have crushed the broader indices, driven by a spectacular bull run in the equity markets. While the COVID-19 pandemic decimated the stock market in early 2020, the snap-back rally pushed major indices to record highs, primarily due to growth stocks in the technology space.

The ongoing pandemic has also acted as a tailwind for several companies, such as WELL Health (TSX:WELL) and CloudMD (TSXV:DOC). The shift towards telehealth solutions has accelerated in the last 15 months due to the need for social distancing and economic lockdowns imposed by several countries. However, this trend is likely to continue in 2021 and beyond, making WELL Health and CloudMD solid long-term bets.

WELL Health has gained 8,700% since IPO

WELL Health has been on an absolute tear since its IPO five years back. WELL stock has returned a staggering 8,700% after it went public, which means a $1,000 investment just after its IPO would be worth close to $88,000 today.

This astonishing growth has been supported by a strong uptick in sales and improvement in profit margins. WELL Health has increased sales from $5.9 million in 2018 to $50.24 million in 2020. Comparatively, its operating loss stood at $2.09 million in 2018, or 35.4% of sales, while in 2020, the company reported an operating loss of $10.4 million, or 20.7% of sales.

WELL Health has aggressively acquired companies in the last two years that have contributed to its top-line growth. After we account for its recent acquisitions of CRH Medical and MyHealth, WELL’s combined pro forma sales will be close to $400 million, while its EBITDA would be $100 million on a run-rate basis.

Analysts tracking WELL stock forecast 2021 sales to rise by 427% to $265 million and by 60% to $423 million in 2022. Its bottom line is also expected to improve from a loss per share of $0.03 in 2020 to earnings per share of $0.06.

WELL Health stock is valued at a price-to-2022-sales multiple of 4.6, which is really cheap considering its growth estimates.

CloudMD stock is valued at a market cap of $535 million

Shares of CloudMD have gained 144% since its IPO in late 2017. However, CMD stock is currently trading 27% below its record high, providing investors an opportunity to buy the dip. In the first quarter of 2021, CloudMD sales were up 187% year over year at $8.8 million. It ended the quarter with a gross margin of 41%, which was attributed to a strong revenue mix.

Similar to WELL Health, CloudMD has also grown inorganically, and the company closed five acquisitions in the March quarter, adding $13 million in annualized sales.

CloudMD has experienced early adoption in its Enterprise Health Solutions division, which has bagged $5 million in new multi-year contracts in the March quarter.

During the earnings call, company CEO Dr. Essam Hamza said, “CloudMD already has a revenue run rate of over $120 million, and through highly profitable acquisitions coupled with organic growth and realization of cost synergies, we expect to be profitable in the second half of 2021.”

The final takeaway

Both WELL Health and CloudMD are exciting bets for investors looking to beat the market. However, if I have to choose a winner, it would have to be WELL Health given its larger revenue base and lower valuation metrics.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

A shopper makes purchases from an online store.
Tech Stocks

1 Canadian Stock Down 28% That’s Pure Long-Term Gold

If there's one strong stock investors should consider, it has to be this top notch tech stock making a comeback.

Read more »

investment research
Tech Stocks

Best Stock to Buy Right Now: Shopify vs Constellation Software

Let's look at two top Canadian growth stocks and determine which may be the better pick for long-term investors right…

Read more »

3 colorful arrows racing straight up on a black background.
Tech Stocks

1 Canadian Tech Stock Poised for Big Growth in 2025

This Canadian tech stock is one that remains undervalued, so what's next for investors?

Read more »

Canadian dollars in a magnifying glass
Tech Stocks

Billionaires Are Selling NVIDIA Stock and Buying This TSX Stock in Bulk

Forget the tech stocks going through ups and downs and stick to this solid tech stock instead.

Read more »

A person uses and AI chat bot
Tech Stocks

Missed Out on Alphabet Stock? My Favourite AI Stock to Buy and Hold

There are some stocks out there that are popular, and some offer major deals on the market today.

Read more »

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

1 Bright Canadian AI Stock Ready to Surge in 2025 and Beyond

Don't run away from tech stocks, this AI stock could surge this year and beyond.

Read more »

A microchip in a circuit board powers artificial intelligence.
Tech Stocks

An AI Giant Hiding in Plain Sight: Why Wall Street Is Missing Shopify’s Tech Edge

Shopify (TSX:SHOP) stock is a top Canadian AI play that could break out to new highs in 2025.

Read more »

Abstract Human Skull representing AI
Tech Stocks

Step Aside, Nvidia: This AI Stock Is the Real Deal for Canadian Investors

Canada has several tech companies pivoting to AI, which isn't the same as pure-breed AI stocks, but that's not necessarily…

Read more »